Myelodysplastic Syndromes (MDS)

3 total trials

Filter these 3 trials by phase, country, sponsor and more.

Open in Search →

Study to Evaluate Imetelstat (GRN163L) in Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Recruitment ended

2024-511348-25-00 10 2015-12-11
A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects with Lower Risk (IPSS Low or Interm … Ended

2024-516296-32-00 3 2021-11-11
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MD … Ended

2023-507154-32-00 1 2017-02-17

Showing 1–3 of 3 trials